Osteoporosis Drugs May Be Linked to Cancer Risk

In CategoryCancer, Drugs and Drug Companies, Osteoporosis
ByRuss Bianchi

 Sept. 2, 2010 — The long-term use of oral bisphosphonate osteoporosis drugs such as Actonel, Boniva, and Fosamax may be associated with a doubling in esophageal cancer risk, but the risk to individual users remains small, researchers say.

Osteoporosis Drugs May Be Linked to Cancer Risk

Share

Tags: ,

Comments are closed.